Joshi, Garima
Parveen, Gulistan
Kaur, Simran
Asuru, Tejeswara Rao
Kharbanda, Naman
Chawla, Anupam
Maiti, Tushar K
Guchhait, Prasenjit https://orcid.org/0000-0002-6601-6692
Funding for this research was provided by:
Biotechnology Industry Research Assistance Council (BT/CS0094/06/22)
Article History
Received: 5 June 2026
Accepted: 17 July 2026
First Online: 5 August 2026
Declarations
Ethics statement: Small animals: The Institutional Animal Ethics Committee (IAEC) of the Regional Centre for Biotechnology (RCB) approved the animal experiment protocol (RCB/IAEC/2023/155), and experiments using the Balb/c mouse strain (RRID: IMSR_JAX_000651) were conducted within the IAEC guidelines in our institute's Experimental Animal Facility (EAF). Biosafety: The Institutional Biosafety Committee (IBSC RCB/IBSC/22-23/463) of RCB and RCGM (BT/IBKP/053/2020) approved the protocol. All the COVID-19-related in vitro and animal experiments were performed in the BSL3 facility.
Consent for publication: Not applicable.
Competing interests: The authors declare that they have no competing interests.